Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, some people do lose hair while taking Mounjaro (tirzepatide), but the medicine itself is rarely the direct cause. Hair shedding during rapid weight loss is a well-recognised phenomenon called telogen effluvium — your body redirects energy away from non-essential functions, and hair follicles temporarily pause their growth cycle. Understanding the pattern of hair loss on Mounjaro can help you tell the difference between a temporary shed and something worth flagging to a prescriber. Mounjaro is a prescription-only medicine; a clinician assesses whether it is suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Hair loss on Mounjaro tends to appear two to four months after treatment starts — not at week one. That delay is the clue. Telogen effluvium works on a lag: a physical stressor (in this case, rapid calorie reduction and weight loss) pushes hair follicles prematurely into the resting phase, and those hairs fall out weeks later rather than immediately.
Tirzepatide itself is not listed as a direct cause of alopecia in the NHS medicines page for tirzepatide, and the clinical trial programme did not identify it as a primary adverse effect on the follicle. What the trials did involve was significant, fast weight loss, and fast weight loss is one of the most consistent triggers of telogen effluvium regardless of how it is achieved, including after bariatric surgery. So the arrow of causation points more towards what the medicine does (drive rapid weight loss) than to tirzepatide acting on hair biology directly.
Worth knowing: stress on the body doesn't have to feel dramatic to disrupt the hair cycle. Even a sustained calorie deficit (the kind most people on Mounjaro maintain comfortably because appetite falls so markedly) is enough of a physiological signal to slow follicle renewal temporarily. You can read more about how Mounjaro relates to hair loss in our more detailed breakdown of this question.
This is the most actionable part. Telogen effluvium triggered by weight loss is rarely just about calories in isolation; the quality of what you eat while losing weight matters considerably for hair health. Three nutrients in particular have a good evidence base for follicle function: protein, iron (especially ferritin stores) and zinc.
When appetite falls sharply (which is a feature of tirzepatide treatment, not a side effect to push through) it becomes easy to eat too little protein without noticing. Hair is almost entirely keratin, a structural protein. If dietary protein drops well below adequate levels during the weight-loss phase, follicles receive less of the raw material they need and shedding can intensify or last longer. A prescriber or dietitian can help you identify a protein target that fits your current intake level without undermining the calorie reduction that makes treatment work.
Iron is the other common culprit, particularly in women. Heavy periods combined with a reduced appetite can deplete ferritin quietly; a simple blood test will show whether stores are low. If you are already tracking your treatment journey with us, our aftercare team can flag whether a GP review of your bloods makes sense at your next check-in.
A general increase in daily shedding (more hairs in the shower or on a brush) is the typical pattern of telogen effluvium, and it tends to peak around three to six months into significant weight loss before gradually resolving as the body adapts. Hair density usually returns once weight stabilises and nutrition catches up. This is the picture described by the NHS England weight-management injections guidance, which notes that some hair thinning can occur during rapid weight loss and generally settles over time.
There are patterns that warrant a different level of attention. Patchy, well-defined bald spots suggest alopecia areata rather than telogen effluvium. Hair loss accompanied by eyebrow thinning, feeling cold, fatigue and dry skin may point to thyroid changes. Scalp redness, scaling or soreness is a separate dermatological matter entirely. Any of these should go to your GP rather than being attributed to Mounjaro or diet.
If you have questions about whether your specific pattern of thinning is consistent with what others on Mounjaro report, our prescribers hear this question most weeks and can put your experience in clinical context. A broader overview of tirzepatide as a treatment, including its licensed indications and eligibility criteria, is on our tirzepatide information page.
Short of stopping treatment (which is rarely the right call, given that the shed is temporary for most people) there are practical things to do now. Prioritise protein at every meal, even when appetite is low; eggs, Greek yoghurt, fish and pulses are compact sources that don't require large portions. Ask your GP to check ferritin if your hair loss started around three months into treatment and is more than moderate. Avoid aggressive heat styling or tight hairstyles while follicles are stressed; the hair that is there is more fragile than usual.
Some people ask about topical minoxidil during the shedding phase. This is not unreasonable, but it is a conversation for your GP or a dermatologist, not something to start unilaterally, and it is worth confirming first that the diagnosis is truly telogen effluvium and not something else. Our Mounjaro and hair page covers the topical treatment question in more detail, including what the evidence actually says about timing.
The fuller picture of whether hair loss on Mounjaro is permanent reassures most readers: permanent follicle damage from weight-loss-related telogen effluvium is not the expected outcome. The follicles are not destroyed; they are resting. That is a meaningful distinction, and it's one our clinical team are happy to discuss with you directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.